Biotech stock Crispr Therapeutics Inc's (NASDAQ:CRSP) June rally appears to be coming to an end. The shares are looking to snap a seven-day win streak, down 0.6% at $42.69 at last glance. Plus, after hitting its highest level since March, the stock is now flashing a historically bearish signal on the charts. Per Schaeffer's Senior Quantitative Analyst Rocky White, CRSP has moved up toward its 260-day moving average. More specifically, the security is within 0.75 of the trendline's 20-day average true range ...